In the US, Tricor (fenofibrate systemic) is a member of the drug class fibric acid derivatives and is used to treat Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL, Hyperlipoproteinemia Type IIb - Elevated LDL VLDL, Hyperlipoproteinemia Type IV - Elevated VLDL, Hyperlipoproteinemia Type V - Elevated Chylomicrons VLDL and Hypertriglyceridemia.
Ingredient matches for Tricor
Adenosine is reported as an ingredient of Tricor in the following countries:
Fenofibrate is reported as an ingredient of Tricor in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- Russian Federation
- United States